SILVERARC CAPITAL MANAGEMENT LLC 13D and 13G filings for Mersana Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-15 06:55 am Sale |
2024-10-11 | 13G | Mersana Therapeutics, Inc. MRSN |
SILVERARC CAPITAL MANAGEMENT LLC | 1,754,086 1.430% |
-4,666,050 (-72.68%) |
Filing |
| 2024-02-14 8:43 pm Purchase |
2023-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
SILVERARC CAPITAL MANAGEMENT LLC | 6,420,136 5.300% |
6,420,136 (New Position) |
Filing |